HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone marrow mesenchymal stromal cells with support of bispecific antibody and ultrasound-mediated microbubbles prevent myocardial fibrosis via the signal transducer and activators of transcription signaling pathway.

AbstractBACKGROUND AIMS:
This study was initiated to investigate the efficacy of myocardial fibrosis intervention via signal transducer and activators of transcription (STAT) signaling using bone marrow (BM) mesenchymal stromal cells (MSC) with the aid of bispecific antibody (BiAb) and ultrasound-mediated microbubbles (MB).
METHODS:
BiAb (anti-CD29 × anti-myosin light chain antibody; AMLCA) was prepared and combined with isolated MSC from male mice and transfused into female mice with isoproterenol-induced myocardial fibrosis via the tail vein, followed by MB (MSC + BiAb + MB). This study included seven groups: MSC + BiAb + MB; MSC; BiAb; MB; MSC + BiAb; untreated; and control. Five weeks after treatment, expression levels of the sex-determining region of Y-chromosome (SRY), matrix metalloproteinases (MMP)-9, tissue inhibitor of metalloproteinase (TIMP)-1 and vascular endothelial growth factor (VEGF) in myocardium were detected by fluorescent quantitative real-time polymerase chain reaction (qRT-PCR). Collagen distribution was observed using Sirius Red staining. The protein expression of signal transducer and activators of transcription (STAT)1 and STAT3 was detected by Western blot.
RESULTS:
The highest homing number of MSC was in the MSC + BiAb + MB group, second highest in the MSC + BiAb group, and lowest in MSC alone. Compared with the untreated group, MSC + BiAb + MB, MSC + BiAb and MSC groups had decreased levels of MMP-9, TIMP-1, STAT1 and collagen deposition, and increased levels of STAT3. Upregulated STAT3 and downregulated TIMP-1 were significantly different in MSC + BiAb + MB compared with MSC alone or MSC + BiAb.
CONCLUSIONS:
The homing rate and repairing efficacy of MSC improved with treatment utilizing a combination of BiAb and MB. MSC can improve MMP-TIMP expression in injured myocardium and interfere with myocardial fibrosis after homing, a mechanism that may be related to the STAT-mediated signaling pathway.
AuthorsWei Deng, Qing-Wei Chen, Xing-Sheng Li, Hao Liu, Si-Qiang Niu, Yue Zhou, Gui-Qiong Li, Da-Zhi Ke, Xian-Gang Mo
JournalCytotherapy (Cytotherapy) Vol. 13 Issue 4 Pg. 431-40 (Apr 2011) ISSN: 1477-2566 [Electronic] England
PMID21174489 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • STAT Transcription Factors
Topics
  • Animals
  • Bone Marrow Cells (cytology)
  • Cardiomyopathies (metabolism, prevention & control)
  • Cells, Cultured
  • Female
  • Fibrosis (metabolism, prevention & control)
  • Male
  • Mesenchymal Stem Cell Transplantation (methods)
  • Mesenchymal Stem Cells (cytology)
  • Mice
  • Mice, Inbred BALB C
  • Microbubbles
  • STAT Transcription Factors (metabolism)
  • Signal Transduction
  • Stromal Cells (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: